Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Antiobesity Market Size?

The market for anti-obesity products has seen robust growth over recent years. Predictions indicate that it will increase from $3.74 billion in 2024 to $4.1 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.7%. The historical growth can be credited to a surge in obesity rates, raised consciousness and education about the condition, changes in lifestyle habits, and government efforts.

The market for antiobesity is predicted to witness robust expansion in the ensuing years, reaching a value of “$5.94 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.7%. This escalation within the forecast period could be due to a number of factors such as market proliferation and globalization. The key trends expected within this period include extensive research and development, a focus on patient-oriented strategies, an increase in insurance coverage, advancements in technology, progress in digital health and telemedicine, the emergence of new drug therapies, improvements in bariatric surgery, over-the-counter (OTC) remedies, behavior-based interventions, and the introduction of nutritional and weight management apps.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

What Underlying Factors Are Supporting The Antiobesity Market Growth?

Worldwide, obesity is recognized as a significant concern for public health. Annually, the global incidence of obesity continues to rise. For example, predictions from the World Obesity Atlas, a UK-based organization focusing on obesity, suggest that by 2030 over 1 billion people worldwide could be dealing with obesity. This is presumed to be due to a rise in processed and unhealthy food consumption, a decrease in physical activity, and inadequate knowledge about obesity-related risks. Consequently, we are likely to witness an upward trend in the demand for anti-obesity medications, thereby stimulating market growth.

What Segmentation Insights Are Provided In The Antiobesity Market Research?

The antiobesity market covered in this report is segmented –

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

Subsegments:

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin

2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

Which Notable Trends Are Transforming The Antiobesity Market Outlook?

Leading businesses within the anti-obesity drugs marketplace are putting their focus on the innovation of new products like Mounjaro (tirzepatide) in order to supply reliable services to their customers. Mounjaro (tirzepatide), an anti-obesity medication, is utilized to treat adults who are obese or overweight and suffer from weight-related health issues. As a case in point, in October 2022, Mounjaro (tirzepatide) was launched by Eli Lilly and Company, a pharmaceutical firm based in the US, with the approval of the FDA, the federal agency in the US, as a treatment under the fast track designation. Mounjaro (tirzepatide) is an injectable form of anti-obesity medication used to support those grappling with obesity in meeting their weight loss objectives. It is recommended for adults with type 2 diabetes, in conjunction with a healthy diet and regular exercise, to regulate their blood sugar (glucose) levels.

Who Are The Leading Companies Driving The Antiobesity Market?

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Antiobesity Market?

North America was the largest region in the anti-obesity market in 2024. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3403&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model